Stereotaxis, Inc.
General ticker "STXS" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $225.8M (TTM average)
Stereotaxis, Inc. does not follow the US Stock Market performance with the rate: -7.1%.
Estimated limits based on current volatility of 6.7%: low 1.50$, high 1.72$
Factors to consider:
- Total employees count: 139 (+13.9%) as of 2024
- US accounted for 49.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Insufficient capital, Supply chain disruptions, Regulatory and compliance, Market competition, Technological obsolescence
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.65$, 3.48$]
- 2026-12-31 to 2027-12-31 estimated range: [1.76$, 3.65$]
Financial Metrics affecting the STXS estimates:
- Positive: with PPE of -11.3 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.04 > -0.60
- Positive: 19.19 < Shareholder equity ratio, % of 25.80 <= 42.57
- Negative: negative Net income
- Positive: -9.70 < Industry operating profit margin (median), % of -3.62
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.67
Short-term STXS quotes
Long-term STXS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $26.77MM | $26.92MM | $32.38MM |
| Operating Expenses | $48.61MM | $51.66MM | $54.49MM |
| Operating Income | $-21.84MM | $-24.74MM | $-22.11MM |
| Non-Operating Income | $1.13MM | $0.69MM | $0.47MM |
| R&D Expense | $10.27MM | $9.76MM | $9.38MM |
| Income(Loss) | $-20.71MM | $-24.05MM | $-21.64MM |
| Net Income(Loss)* | $-20.71MM | $-24.05MM | $-21.64MM |
| Stockholders Equity | $21.92MM | $6.08MM | $13.48MM |
| Inventory | $8.43MM | $8.33MM | $9.57MM |
| Assets | $41.91MM | $46.72MM | $52.25MM |
| Operating Cash Flow | $-9.14MM | $-8.50MM | $-13.69MM |
| Capital expenditure | $0.37MM | $0.03MM | $0.09MM |
| Investing Cash Flow | $19.77MM | $0.07MM | $-0.09MM |
| Financing Cash Flow | $0.08MM | $0.30MM | $14.76MM |
| Earnings Per Share** | $-0.26 | $-0.28 | $-0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.